Slingshot members are tracking this event:

Phase 3 overall survival data of CPX-351 for Secondary AML due 1Q 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 14, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Secondary Aml, Phase 3, Cpx-351, Vyxeos, Combiplex, Aacr-nci-eortc